Molecular Data Statistics
Total Valuation
Molecular Data has a market cap or net worth of $4,873.
| Market Cap | 4,873 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Molecular Data has 12.18 million shares outstanding.
| Shares Outstanding | 12.18M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.58% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $5.94M |
| Profits Per Employee | -$64,021 |
| Employee Count | 189 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Molecular Data has paid $21,684 in taxes.
| Income Tax | 21,684 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 1.34, so Molecular Data's price volatility has been higher than the market average.
| Beta (1Y) | 1.34 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.91 |
| Average Volume (30 Days) | 1,952 |
Short Selling Information
The latest short interest is 491,508, so 4.03% of the outstanding shares have been sold short.
| Short Interest | 491,508 |
| Short Previous Month | 465,260 |
| Short % of Shares Out | 4.03% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.39 |
Income Statement
In the last 12 months, Molecular Data had revenue of $1.12 billion and -$12.10 million in losses. Loss per share was -$1.16.
| Revenue | 1.12B |
| Gross Profit | 9.58M |
| Operating Income | -12.15M |
| Pretax Income | -12.04M |
| Net Income | -12.10M |
| EBITDA | -11.80M |
| EBIT | -12.04M |
| Loss Per Share | -$1.16 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity / Book Value | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$19.84 million and capital expenditures -$146,957, giving a free cash flow of -$19.98 million.
| Operating Cash Flow | -19.84M |
| Capital Expenditures | -146,957 |
| Free Cash Flow | -19.98M |
| FCF Per Share | -$1.64 |
Margins
Gross margin is 0.85%, with operating and profit margins of -1.08% and -1.08%.
| Gross Margin | 0.85% |
| Operating Margin | -1.08% |
| Pretax Margin | -1.07% |
| Profit Margin | -1.08% |
| EBITDA Margin | -1.05% |
| EBIT Margin | -1.07% |
| FCF Margin | -1.78% |
Dividends & Yields
Molecular Data does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -248,305.81% |
| FCF Yield | -410,081.83% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 23, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | May 23, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |